PITTSBURGH, PA, July 16, 2015 -- Evoqua Water Technologies, a specialist in water and wastewater treatment products, has been awarded a renewal contract to supply the U.S. Food & Drug Administration's (FDA) Arkansas Regional Laboratory in Jefferson, Ark., with its state-of-the-art ultrapure laboratory deionized water system.
The success of FDA activities to protect public health often depends on the ability of the Agency's laboratories to quickly and accurately analyze samples. Ultrapure water is key to accurate analysis and suggesting corrective action.
The contract awarded to Evoqua renews a five-year agreement with the FDA where Evoqua has supplied reverse osmosis, control systems and deionization to meet its pure water needs. The contract also calls for Evoqua to provide ongoing service of the equipment and systems.
The Arkansas Regional Lab, a 146,400-square foot facility, was built as part of FDA's plan to reorganize its 18 field laboratories within its Office of Regulatory Affairs. The Arkansas Regional Lab consists of a Director's Office, General Chemistry Branch, Pesticide Chemistry Branch, Veterinary Sciences Branch, Microbiology Branch, Animal Drug Research Center and a Total Diet and Pesticide Research Center.
About Evoqua Water Technologies
Evoqua Water Technologies is a specialist in water and wastewater treatment products, systems and services for industrial and municipal customers. Its comprehensive, cost-effective and reliable treatment systems and services reduce fresh water demand, ensure uninterrupted quantity and quality of water, and enable regulatory and environmental compliance. With a wide range of proven product brands and advanced water and wastewater treatment technologies, mobile and emergency water supply solutions and service contract options, Evoqua helps cities provide clean water and industrial plants to maintain productivity and profitability. For more information, visit www.evoqua.com.